BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

340 related articles for article (PubMed ID: 23105114)

  • 1. Retinoic acid induces neurogenesis by activating both retinoic acid receptors (RARs) and peroxisome proliferator-activated receptor β/δ (PPARβ/δ).
    Yu S; Levi L; Siegel R; Noy N
    J Biol Chem; 2012 Dec; 287(50):42195-205. PubMed ID: 23105114
    [TBL] [Abstract][Full Text] [Related]  

  • 2. All-trans-retinoic acid represses obesity and insulin resistance by activating both peroxisome proliferation-activated receptor beta/delta and retinoic acid receptor.
    Berry DC; Noy N
    Mol Cell Biol; 2009 Jun; 29(12):3286-96. PubMed ID: 19364826
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Overcoming retinoic acid-resistance of mammary carcinomas by diverting retinoic acid from PPARbeta/delta to RAR.
    Schug TT; Berry DC; Toshkov IA; Cheng L; Nikitin AY; Noy N
    Proc Natl Acad Sci U S A; 2008 May; 105(21):7546-51. PubMed ID: 18495924
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stable over-expression of PPARβ/δ and PPARγ to examine receptor signaling in human HaCaT keratinocytes.
    Borland MG; Khozoie C; Albrecht PP; Zhu B; Lee C; Lahoti TS; Gonzalez FJ; Peters JM
    Cell Signal; 2011 Dec; 23(12):2039-50. PubMed ID: 21843636
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Non-classical Transcriptional Activity of Retinoic Acid.
    Noy N
    Subcell Biochem; 2016; 81():179-199. PubMed ID: 27830505
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Curcumin restores sensitivity to retinoic acid in triple negative breast cancer cells.
    Thulasiraman P; McAndrews DJ; Mohiudddin IQ
    BMC Cancer; 2014 Sep; 14():724. PubMed ID: 25260874
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Opposing effects of retinoic acid on cell growth result from alternate activation of two different nuclear receptors.
    Schug TT; Berry DC; Shaw NS; Travis SN; Noy N
    Cell; 2007 May; 129(4):723-33. PubMed ID: 17512406
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Saturated fatty acids regulate retinoic acid signalling and suppress tumorigenesis by targeting fatty acid-binding protein 5.
    Levi L; Wang Z; Doud MK; Hazen SL; Noy N
    Nat Commun; 2015 Nov; 6():8794. PubMed ID: 26592976
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fatty acid-binding protein 5 (FABP5) regulates cognitive function both by decreasing anandamide levels and by activating the nuclear receptor peroxisome proliferator-activated receptor β/δ (PPARβ/δ) in the brain.
    Yu S; Levi L; Casadesus G; Kunos G; Noy N
    J Biol Chem; 2014 May; 289(18):12748-58. PubMed ID: 24644281
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Kruppel-like factor 2 suppresses mammary carcinoma growth by regulating retinoic acid signaling.
    Zhang W; Levi L; Banerjee P; Jain M; Noy N
    Oncotarget; 2015 Nov; 6(34):35830-42. PubMed ID: 26416422
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Peroxisome proliferator-activated receptor-β/δ inhibits human neuroblastoma cell tumorigenesis by inducing p53- and SOX2-mediated cell differentiation.
    Yao PL; Chen L; Dobrzański TP; Zhu B; Kang BH; Müller R; Gonzalez FJ; Peters JM
    Mol Carcinog; 2017 May; 56(5):1472-1483. PubMed ID: 27996177
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nolz1 promotes striatal neurogenesis through the regulation of retinoic acid signaling.
    Urbán N; Martín-Ibáñez R; Herranz C; Esgleas M; Crespo E; Pardo M; Crespo-Enríquez I; Méndez-Gómez HR; Waclaw R; Chatzi C; Alvarez S; Alvarez R; Duester G; Campbell K; de Lera AR; Vicario-Abejón C; Martinez S; Alberch J; Canals JM
    Neural Dev; 2010 Aug; 5():21. PubMed ID: 20735826
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Retinoic acid as cause of cell proliferation or cell growth inhibition depending on activation of one of two different nuclear receptors.
    Wolf G
    Nutr Rev; 2008 Jan; 66(1):55-9. PubMed ID: 18254885
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Guiding ligands to nuclear receptors.
    Michalik L; Wahli W
    Cell; 2007 May; 129(4):649-51. PubMed ID: 17512397
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Retinoic acid is a high affinity selective ligand for the peroxisome proliferator-activated receptor beta/delta.
    Shaw N; Elholm M; Noy N
    J Biol Chem; 2003 Oct; 278(43):41589-92. PubMed ID: 12963727
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Retinoic acid regulates cell-shape and -death of E-FABP (FABP5)-immunoreactive septoclasts in the growth plate cartilage of mice.
    Bando Y; Yamamoto M; Sakiyama K; Sakashita H; Taira F; Miyake G; Iseki S; Owada Y; Amano O
    Histochem Cell Biol; 2017 Sep; 148(3):229-238. PubMed ID: 28500502
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CRABP-II- and FABP5-independent all-trans retinoic acid resistance in COLO 16 human cutaneous squamous cancer cells.
    Chen NN; Li Y; Wu ML; Liu ZL; Fu YS; Kong QY; Chen XY; Li H; Liu J
    Exp Dermatol; 2012 Jan; 21(1):13-8. PubMed ID: 22082219
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ligand activation of peroxisome proliferator-activated receptor-beta/delta inhibits cell proliferation in human HaCaT keratinocytes.
    Borland MG; Foreman JE; Girroir EE; Zolfaghari R; Sharma AK; Amin S; Gonzalez FJ; Ross AC; Peters JM
    Mol Pharmacol; 2008 Nov; 74(5):1429-42. PubMed ID: 18687807
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regulation of retinoid-induced differentiation in embryonal carcinoma PCC4.aza1R cells: effects of retinoid-receptor selective ligands.
    Mills KJ; Vollberg TM; Nervi C; Grippo JF; Dawson MI; Jetten AM
    Cell Growth Differ; 1996 Mar; 7(3):327-37. PubMed ID: 8838863
    [TBL] [Abstract][Full Text] [Related]  

  • 20. LIM protein Ajuba functions as a nuclear receptor corepressor and negatively regulates retinoic acid signaling.
    Hou Z; Peng H; White DE; Negorev DG; Maul GG; Feng Y; Longmore GD; Waxman S; Zelent A; Rauscher FJ
    Proc Natl Acad Sci U S A; 2010 Feb; 107(7):2938-43. PubMed ID: 20133701
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.